Keap1-Nrf2/ARE抗氧化通路在肿瘤中的研究进展
云图娅 苏秀兰[摘要] 活性氧可通过攻击损伤脱氧核糖核酸或核糖核酸造成细胞突变,诱导细胞癌变。Keap1-Nrf2/ARE是机体重要的氧化应激通路,Nrf2作为该系统的主效应因子,通过激活调控机体内多种Ⅱ相解毒酶的表达预防正常细胞恶变,发挥抗癌作用。有细胞及动物实验证明Nrf2可以促进肿瘤的发展,同时也能增加肿瘤细胞对化疗药物的耐受性。研究Keap1-Nrf2/ARE通路信号转导对于肿瘤的预防、发展和靶向治疗至关重要。
[关键词] 氧化应激;Keap1-Nrf2/ARE通路;肿瘤;耐药
[中图分类号] R73 ? ? ? ? ?[文献标识码] A ? ? ? ? ?[文章编号] 1673-7210(2019)10(a)-0056-04
Research progress of Keap1-Nrf2/ARE antioxidant pathway in tumors
YUN Tuya ? SU Xiulan
Clinical Medicine Research Center, Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia Autonomous Region, Hohhot ? 010030, China
[Abstract] Reactive oxygen species can cause cell mutation and induce cell carcinogenesis by attacking deoxyribonucleic acid or ribonucleic acid. Keap1-Nrf2/ARE is an important oxidative stress pathway in the body. As the main effector of this system, Nrf2 can prevent malignant transformation of normal cells and play an anti-cancer role by activating and regulating the expression of various phase Ⅱ detoxifying enzymes in the body. Cellular and animal experiments have shown that Nrf2 can promote the development of tumors and increase the tolerance of cancer cells to chemotherapeutic drugs. Research on signal transduction of Keap1-Nrf2/ARE pathway is essential for cancer prevention ......
您现在查看是摘要页,全文长 14004 字符。